首页> 外文期刊>Medicine. >Nonalcoholic Fatty Liver Disease: A Negative Risk Factor for Colorectal Cancer Prognosis
【24h】

Nonalcoholic Fatty Liver Disease: A Negative Risk Factor for Colorectal Cancer Prognosis

机译:非酒精性脂肪肝疾病:结直肠癌预后的负面危险因素。

获取原文
获取外文期刊封面目录资料

摘要

Abstract: Nonalcoholic fatty liver disease (NAFLD) is known to be associated with an increased risk of colorectal cancer (CRC). However, the relationship between NAFLD and the prognosis of CRC remains unclear. The primary objective of this study was to evaluate the overall survival (OS) and disease-free survival (DFS) rates in patients with CRC and the secondary objective was to compare clinicopathologic variables which were stratified by NAFLD. We performed a large cohort study of 1314 patients who were first diagnosed with CRC between January 2006 and April 2011. Postoperative follow-up data were collected from out-patient medical records, telephone consultations, and social security death indices. The Kaplan–Meier method was used to calculate the cumulative survival rate. Clinicopathologic variables were analyzed by univariate analysis and multivariate analysis through a Cox proportional hazard regression model. The mean follow-up time was 52.7?±?25.3 months. Upon baseline comparison, the NAFLD group had significantly higher values of body mass index, triglycerides, and uric acid and significantly lower values of high-density lipoprotein, compared with the non-NAFLD group (P?P?=?0.075, P?=?0.002, P?=?0.030, respectively). There was no difference in DFS rates between the CRC patients with and without NAFLD (P?=?0.267). Multivariate analysis showed that the presence of NAFLD was an independent negative risk factor for OS after adjusting for clinicopathologic covariates (hazard ratio?=?0.593; 95% confidence interval 0.442, 0.921; P?=?0.020), but not for DFS (P?=?0.270). NAFLD may play a protective role in OS for CRC patients. Further studies are needed to elucidate the molecular mechanisms of putative protective effects in CRC patients with NAFLD.
机译:摘要:已知非酒精性脂肪肝疾病(NAFLD)与大肠癌(CRC)风险增加有关。然而,NAFLD与CRC预后之间的关系仍不清楚。这项研究的主要目的是评估CRC患者的总生存率(OS)和无病生存率(DFS),次要目的是比较通过NAFLD分层的临床病理变量。我们对2006年1月至2011年4月之间首次诊断为CRC的1314例患者进行了一项大型队列研究。术后随访数据来自门诊医疗记录,电话咨询和社会保障死亡指数。 Kaplan–Meier方法用于计算累积生存率。临床病理变量通过单变量分析和多变量分析通过Cox比例风险回归模型进行分析。平均随访时间为52.7±25.3个月。通过基线比较,与非NAFLD组相比,NAFLD组的体重指数,甘油三酸酯和尿酸值明显较高,而高密度脂蛋白的值则明显较低(P≥P≥0.075,P≥分别为0.002,P = 0.030。有和没有NAFLD的CRC患者之间的DFS率无差异(P = 0.267)。多因素分析显示,在调整了临床病理协变量后,NAFLD的存在是OS的独立负危险因素(危险比≤0.593; 95%置信区间0.442、0.921; P≤0.020),而不是DFS(P = 0.270)。 NAFLD可能在CRC患者OS中起保护作用。需要进一步的研究阐明在患有NAFLD的CRC患者中假定的保护作用的分子机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号